PD Dr. Markus Eckstein



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Validity of tissue homogeneity in confocal laser endomicroscopy on the diagnosis of laryngeal and hypopharyngeal squamous cell carcinoma (2022) Sievert M, Aubreville M, Gostian AO, Mantsopoulos K, Koch M, Müller-Hübner SKU, Eckstein M, et al. Journal article The COVID-19 pandemic and its consequences for the diagnosis and therapy of head and neck malignancies (2022) Rupp R, de Vasconcelos Craveiro A, Allner M, Grundtner P, Eckstein M, Hecht M, Iro H, et al. Journal article The outcome of patients with inflammatory bowel disease-associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer-a matched-pair analysis of survival (2021) Vitali F, Wein A, Rath T, Eckstein M, Neufert C, Siebler J, Atreya R, et al. Journal article Novel criteria for intratumoral budding with prognostic relevance for colon cancer and its histological subtypes (2021) Pour Farid P, Eckstein M, Merkel S, Grützmann R, Hartmann A, Bruns V, Benz M, et al. Journal article Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer (2021) Eckstein M, Kimmel C, Bruendl J, Weber F, Denzinger S, Gierth M, Burger M, et al. Journal article MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer (2021) Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, et al. Journal article Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors (2021) Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, et al. Journal article Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP) (2021) Balk M, Rupp R, Mantsopoulos K, Allner M, Grundtner P, Müller-Hübner SKU, Traxdorf M, et al. Journal article Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome (2021) Willner A, Fechner K, Agaimy A, Haller F, Eckstein M, Ott O, Putz F, et al. Journal article Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (2021) Hellwig K, Ellmann S, Eckstein M, Wiesmüller M, Rutzner S, Semrau S, Frey B, et al. Journal article